Skip to main content
Erschienen in: World Journal of Surgery 2/2011

01.02.2011

Correlation Between Tumor Budding and Post-Resection Prognosis in Patients with Invasive Squamous Cell Carcinoma of the Thoracic Esophagus

verfasst von: Yoshitsugu Nakanishi, Masanori Ohara, Hiromitsu Doumen, Noriko Kimura, Takuzo Ishidate, Satoshi Kondo

Erschienen in: World Journal of Surgery | Ausgabe 2/2011

Einloggen, um Zugang zu erhalten

Abstract

Background

Tumor budding is defined as an isolated single cancer cell or a cluster of cancer cells composed of fewer than five cells at the invasive front of a tumor. The aim of the present study was to identify correlations between tumor budding and clinicopathological factors and their impact on postoperative prognosis in invasive squamous cell carcinoma of the thoracic esophagus.

Methods

The subjects were 82 patients who underwent curative resection. The number of tumors showing budding was counted immunohistochemically based on positivity for cytokeratin (AE1/AE3) to distinguish cancer cells from inflammatory cells, and the patients were divided into low-grade and high-grade budding groups. High-grade budding was defined as ≥5 budding foci per field under a 20× objective lens.

Results

One group of 36 patients (43.9%) and a second group of 46 patients (56.1%) were classified into the low-grade and high-grade budding groups, respectively. Patients in the high-grade budding group had significantly larger tumor size, deeper depth of invasion, more frequent lymphatic invasion and venous invasion, as well as more lymph node metastases, than those in the low-grade budding group. Disease-free and overall survivals were worse in the high-grade budding group than in the low-grade budding group (P < 0.0001 and P = 0.0002, respectively). Three of four patients who had tumor recurrence more than 5 years postoperatively belonged to the low-grade budding group.

Conclusions

Tumor budding appears to be an indicator of tumor growth and invasiveness. Patients with low-grade budding are likely to have a better prognosis than those with high-grade budding, but the tumor may recur in the late phase postoperatively in patients with low-grade budding.
Literatur
1.
Zurück zum Zitat Ueno H, Mochizuki H, Hashiguchi Y et al (2004) Risk factors for an adverse outcome in early invasive colorectal carcinoma. Gastroenterology 127:385–394CrossRefPubMed Ueno H, Mochizuki H, Hashiguchi Y et al (2004) Risk factors for an adverse outcome in early invasive colorectal carcinoma. Gastroenterology 127:385–394CrossRefPubMed
3.
Zurück zum Zitat Ueno H, Murphy J, Jass JR et al (2002) Tumour “budding” as an index to estimate the potential of aggressiveness in rectal cancer. Histopathology 40:127–132CrossRefPubMed Ueno H, Murphy J, Jass JR et al (2002) Tumour “budding” as an index to estimate the potential of aggressiveness in rectal cancer. Histopathology 40:127–132CrossRefPubMed
4.
Zurück zum Zitat Tanaka M, Hashiguchi Y, Ueno H et al (2003) Tumor budding at the invasive margin can predict patients at high risk of recurrence after curative surgery for stage II, T3 colon cancer. Dis Colon Rectum 46:1054–1059CrossRefPubMed Tanaka M, Hashiguchi Y, Ueno H et al (2003) Tumor budding at the invasive margin can predict patients at high risk of recurrence after curative surgery for stage II, T3 colon cancer. Dis Colon Rectum 46:1054–1059CrossRefPubMed
5.
Zurück zum Zitat Ueno H, Price AB, Wilkinson KH et al (2004) A new prognostic staging system for rectal cancer. Ann Surg 240:832–839CrossRefPubMed Ueno H, Price AB, Wilkinson KH et al (2004) A new prognostic staging system for rectal cancer. Ann Surg 240:832–839CrossRefPubMed
6.
Zurück zum Zitat Lugli A, Karamitopoulou E, Panayiotides I et al (2009) CD8+ lymphocytes/tumour-budding index: an independent prognostic factor representing a “pro-/anti-tumour” approach to tumour host interaction in colorectal cancer. Br J Cancer 101:1382–1392CrossRefPubMed Lugli A, Karamitopoulou E, Panayiotides I et al (2009) CD8+ lymphocytes/tumour-budding index: an independent prognostic factor representing a “pro-/anti-tumour” approach to tumour host interaction in colorectal cancer. Br J Cancer 101:1382–1392CrossRefPubMed
7.
Zurück zum Zitat Kazama S, Watanabe T, Ajioka Y et al (2006) Tumour budding at the deepest invasive margin correlates with lymph node metastasis in submucosal colorectal cancer detected by anticytokeratin antibody CAM5.2. Br J Cancer 94:293–298CrossRefPubMed Kazama S, Watanabe T, Ajioka Y et al (2006) Tumour budding at the deepest invasive margin correlates with lymph node metastasis in submucosal colorectal cancer detected by anticytokeratin antibody CAM5.2. Br J Cancer 94:293–298CrossRefPubMed
8.
Zurück zum Zitat Ueno H, Mochizuki H, Hashiguchi Y et al (2004) Predictors of extrahepatic recurrence after resection of colorectal liver metastases. Br J Surg 91:327–333CrossRefPubMed Ueno H, Mochizuki H, Hashiguchi Y et al (2004) Predictors of extrahepatic recurrence after resection of colorectal liver metastases. Br J Surg 91:327–333CrossRefPubMed
9.
Zurück zum Zitat Okuyama T, Oya M, Ishikawa H (2003) Budding as a useful prognostic marker in pT3 well- or moderately-differentiated rectal adenocarcinoma. J Surg Oncol 83:42–47CrossRefPubMed Okuyama T, Oya M, Ishikawa H (2003) Budding as a useful prognostic marker in pT3 well- or moderately-differentiated rectal adenocarcinoma. J Surg Oncol 83:42–47CrossRefPubMed
10.
Zurück zum Zitat Park KJ, Choi HJ, Roh MS et al (2005) Intensity of tumor budding and its prognostic implications in invasive colon carcinoma. Dis Colon Rectum 48:1597–1602CrossRefPubMed Park KJ, Choi HJ, Roh MS et al (2005) Intensity of tumor budding and its prognostic implications in invasive colon carcinoma. Dis Colon Rectum 48:1597–1602CrossRefPubMed
11.
Zurück zum Zitat Yasuda K, Inomata M, Shiromizu A et al (2007) Risk factors for occult lymph node metastasis of colorectal cancer invading the submucosa and indications for endoscopic mucosal resection. Dis Colon Rectum 50:1370–1376CrossRefPubMed Yasuda K, Inomata M, Shiromizu A et al (2007) Risk factors for occult lymph node metastasis of colorectal cancer invading the submucosa and indications for endoscopic mucosal resection. Dis Colon Rectum 50:1370–1376CrossRefPubMed
12.
Zurück zum Zitat Hase K, Shatney C, Johnson D et al (1993) Prognostic value of tumor “budding” in patients with colorectal cancer. Dis Colon Rectum 36:627–635CrossRefPubMed Hase K, Shatney C, Johnson D et al (1993) Prognostic value of tumor “budding” in patients with colorectal cancer. Dis Colon Rectum 36:627–635CrossRefPubMed
13.
Zurück zum Zitat Roh MS, Lee JI, Choi PJ (2004) Tumor budding as a useful prognostic marker in esophageal squamous cell carcinoma. Dis Esophagus 17:333–337CrossRefPubMed Roh MS, Lee JI, Choi PJ (2004) Tumor budding as a useful prognostic marker in esophageal squamous cell carcinoma. Dis Esophagus 17:333–337CrossRefPubMed
14.
Zurück zum Zitat Koike M, Kodera Y, Itoh Y et al (2008) Multivariate analysis of the pathologic features of esophageal squamous cell cancer: tumor budding is a significant independent prognostic factor. Ann Surg Oncol 15:1977–1982CrossRefPubMed Koike M, Kodera Y, Itoh Y et al (2008) Multivariate analysis of the pathologic features of esophageal squamous cell cancer: tumor budding is a significant independent prognostic factor. Ann Surg Oncol 15:1977–1982CrossRefPubMed
15.
Zurück zum Zitat Miyata H, Yoshioka A, Yamasaki M et al (2009) Tumor budding in tumor invasive front predicts prognosis and survival of patients with esophageal squamous cell carcinomas receiving neoadjuvant chemotherapy. Cancer 115:3324–3334CrossRefPubMed Miyata H, Yoshioka A, Yamasaki M et al (2009) Tumor budding in tumor invasive front predicts prognosis and survival of patients with esophageal squamous cell carcinomas receiving neoadjuvant chemotherapy. Cancer 115:3324–3334CrossRefPubMed
16.
Zurück zum Zitat Sobin LH, Gospodarowicz MK, Wittekind C, International Union Against Cancer (2009) TNM classification of malignant tumours. Wiley-Blackwell, Chichester, UK/Hoboken, NJ Sobin LH, Gospodarowicz MK, Wittekind C, International Union Against Cancer (2009) TNM classification of malignant tumours. Wiley-Blackwell, Chichester, UK/Hoboken, NJ
17.
Zurück zum Zitat Zlobec I, Lugli A (2009) Invasive front of colorectal cancer: dynamic interface of pro-/anti-tumor factors. World J Gastroenterol 15:5898–5906CrossRefPubMed Zlobec I, Lugli A (2009) Invasive front of colorectal cancer: dynamic interface of pro-/anti-tumor factors. World J Gastroenterol 15:5898–5906CrossRefPubMed
18.
Zurück zum Zitat Liotta LA, Stetler-Stevenson WG, Steeg PS (1991) Cancer invasion and metastasis: positive and negative regulatory elements. Cancer Invest 9:543–551CrossRefPubMed Liotta LA, Stetler-Stevenson WG, Steeg PS (1991) Cancer invasion and metastasis: positive and negative regulatory elements. Cancer Invest 9:543–551CrossRefPubMed
19.
Zurück zum Zitat Bates RC, Mercurio AM (2005) The epithelial-mesenchymal transition (EMT) and colorectal cancer progression. Cancer Biol Ther 4:365–370CrossRefPubMed Bates RC, Mercurio AM (2005) The epithelial-mesenchymal transition (EMT) and colorectal cancer progression. Cancer Biol Ther 4:365–370CrossRefPubMed
20.
Zurück zum Zitat Natalwala A, Spychal R, Tselepis C (2008) Epithelial-mesenchymal transition mediated tumourigenesis in the gastrointestinal tract. World J Gastroenterol 14:3792–3797CrossRefPubMed Natalwala A, Spychal R, Tselepis C (2008) Epithelial-mesenchymal transition mediated tumourigenesis in the gastrointestinal tract. World J Gastroenterol 14:3792–3797CrossRefPubMed
21.
Zurück zum Zitat Nair KS, Naidoo R, Chetty R (2005) Expression of cell adhesion molecules in oesophageal carcinoma and its prognostic value. J Clin Pathol 58:343–351CrossRefPubMed Nair KS, Naidoo R, Chetty R (2005) Expression of cell adhesion molecules in oesophageal carcinoma and its prognostic value. J Clin Pathol 58:343–351CrossRefPubMed
Metadaten
Titel
Correlation Between Tumor Budding and Post-Resection Prognosis in Patients with Invasive Squamous Cell Carcinoma of the Thoracic Esophagus
verfasst von
Yoshitsugu Nakanishi
Masanori Ohara
Hiromitsu Doumen
Noriko Kimura
Takuzo Ishidate
Satoshi Kondo
Publikationsdatum
01.02.2011
Verlag
Springer-Verlag
Erschienen in
World Journal of Surgery / Ausgabe 2/2011
Print ISSN: 0364-2313
Elektronische ISSN: 1432-2323
DOI
https://doi.org/10.1007/s00268-010-0880-y

Weitere Artikel der Ausgabe 2/2011

World Journal of Surgery 2/2011 Zur Ausgabe

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

S3-Leitlinie „Diagnostik und Therapie des Karpaltunnelsyndroms“

Karpaltunnelsyndrom BDC Leitlinien Webinare
CME: 2 Punkte

Das Karpaltunnelsyndrom ist die häufigste Kompressionsneuropathie peripherer Nerven. Obwohl die Anamnese mit dem nächtlichen Einschlafen der Hand (Brachialgia parästhetica nocturna) sehr typisch ist, ist eine klinisch-neurologische Untersuchung und Elektroneurografie in manchen Fällen auch eine Neurosonografie erforderlich. Im Anfangsstadium sind konservative Maßnahmen (Handgelenksschiene, Ergotherapie) empfehlenswert. Bei nicht Ansprechen der konservativen Therapie oder Auftreten von neurologischen Ausfällen ist eine Dekompression des N. medianus am Karpaltunnel indiziert.

Prof. Dr. med. Gregor Antoniadis
Berufsverband der Deutschen Chirurgie e.V.

S2e-Leitlinie „Distale Radiusfraktur“

Radiusfraktur BDC Leitlinien Webinare
CME: 2 Punkte

Das Webinar beschäftigt sich mit Fragen und Antworten zu Diagnostik und Klassifikation sowie Möglichkeiten des Ausschlusses von Zusatzverletzungen. Die Referenten erläutern, welche Frakturen konservativ behandelt werden können und wie. Das Webinar beantwortet die Frage nach aktuellen operativen Therapiekonzepten: Welcher Zugang, welches Osteosynthesematerial? Auf was muss bei der Nachbehandlung der distalen Radiusfraktur geachtet werden?

PD Dr. med. Oliver Pieske
Dr. med. Benjamin Meyknecht
Berufsverband der Deutschen Chirurgie e.V.

S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“

Appendizitis BDC Leitlinien Webinare
CME: 2 Punkte

Inhalte des Webinars zur S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“ sind die Darstellung des Projektes und des Erstellungswegs zur S1-Leitlinie, die Erläuterung der klinischen Relevanz der Klassifikation EAES 2015, die wissenschaftliche Begründung der wichtigsten Empfehlungen und die Darstellung stadiengerechter Therapieoptionen.

Dr. med. Mihailo Andric
Berufsverband der Deutschen Chirurgie e.V.